人类肺部SARS-CoV-2感染的空气-液体接口培养揭示了基底细胞作为相关目标

Morris Baumgardt1, Benedikt Obermayer2, Anita Balázs3,4

  • 1Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Infectious Diseases, Respiratory Medicine and Critical Care, Berlin, Germany.

概括

严重急性呼吸道综合征冠状病毒2 (SARS-CoV-2) 感染上呼吸道的基底细胞,导致免疫反应. 卡莫斯塔特甲基酸盐治疗减少了病毒载量和免疫激活.